Category Archives: RESEARCH, STUDIES, DOCUMENTATION

HPV vaccine

EXCERPT: 

HPV vaccination is recommended for all girls age 11 to 12, with “catch-up” doses for girls and women from 13 to 26 who haven’t been vaccinated (there are no booster recommendation as of yet).[*]

Both vaccines are available for females. Only Gardasil is available for males (recommended ages 11-21).[*][*]

At this time, protection against cervical intraepithelial neoplasia grade 2/3 (CIN 2/3) is 5 years for Gardasil and 8.4 years for Cervarix.[*]

If your daughter receives an HPV vaccine at the recommended age of 11, protection will have waned by age 16.

The data collected from the above agency confirms approximately 0.0% deaths from cervical cancer under age 20.[*]

What is “one less” then 0%?

READ MORE…

Kaiser Data collection vs. VAERS “Big Discrepancy”

Kaiser Study Donahue CDC- spontaneous_abortion_following_second_flu_vaccine_2017

Kaiser and another care provider (the 6 VSD organizations collaborating on this paper) found greater than 900 possible spontaneous abortion records associated with the flu vaccine for pregnant women.  Yet a search of VAERS using an approximation of their parameters from their supplemental tables #1 Supplemental file for the manuscript failed to find any spontaneous abortions from the healthcare providers in the states these organizations serve in the flu seasons (2010-11 and 2011-2012).

So it appears that these major providers are not reporting to VAERS as they are required to do by law.  The study, however, does not break down the SAs per flu season.

Supplementary Table 1 #1 Supplemental file for the manuscript

What this means:

# 1 Kaiser & Kaiser associated care providers are not reporting to VAERS so that the public does not know what is going and researchers have invalid data.   Kaiser, etc. are reporting to their own VSD data bank >900 SAs in two seasons and not a one is reported in VAERS during the same time period.

#2 We can actually calculate and define by this study “how under-reported VAERS is”

#3 Consider the harm to the public (pregnant) women when the real miscarriage data is hidden.

#4 Consider that the PREP act states that everyone must be adjudicated by the Vaccine Court with the exception that a lawsuit can commence to entities outside the Vaccine Court if there is “willful misconduct”

#5  The Goldman HET study covered three seasons: 2008/9, 2009/10, 2010/11  Off hand we see that there is a disconnect between our research data from VAERS in 2010/11 and the data from VSD. The supplements will help us pin point the SAs in 2010/11, so we can see the disparity.

#6 VLA COMMENT: Between Kaiser Permante data  (VSD) collection reporting fetal deaths from the flu shot 900X more than VAERS while VAERS had 0 reports, what does that say for the accuracy and reliability of independent researchers using VAERS as source. VSD is unavailable to independent researchers.  One thing President Trump might do with the Independent Vaccine Science and Safety Commision is to allow Independent researchers to access the KAISER DATA since the CDC pays for it with Taxpayer dollars.

DTaP vaccine for Pregnant Women Adverse Events and AUTISM

Prenatal Tetanus, Diphtheria,Acellular Pertussis Vaccination and Autism Spectrum Disorder

      Adverse Events:

increased risk of lower birthweight
increased risk of preterm birth
hard selection against males
increased risk of gestational diabetes
increased risk of gestational hypertension
earlier need for prenatal care

Read Study

VLA COMMENT: First it was the flu shot despite Dr. Gary Goldman’s study that there was an increase of fetal death reports by 4,250%CDC recommends pregnant women get the whooping cough vaccine between 27 and 36 weeks of each pregnancy, preferably during the earlier part of this time period. The American College of Obstetricians and Gynecologists and the American College of Nurse-Midwives support this recommendation.

Invitro vaccine recomendations:

Some doctors may hesitate to immunize pregnant women, but the committee assures us this is due to the possibility for congenital anomalies or spontaneous abortions being falsely attributed to the vaccination. There are very few vaccinations contraindicated during pregnancy , and in some cases the benefits of the vaccination outweigh the risks. This is especially true in instances of military service or travel to countries where a disease is highly prevalent, occupations that present risks for exposure to a disease, and those who are immuno-compromised or chronically ill. (read more..)

Study Shows: Everyday ‘Drugs’ Cause More Harm Than the Illegal Ones

Regarding addiction, an estimated 63 million people worldwide were dependent on alcohol in 2015, with about 843 cases of  alcohol dependence per 100,000 people. For comparison, about 20 million people were dependent on marijuana (260 cases per 100,000 people) and 17 million were dependent on opioids (220 cases per 100,000 people) in 2015.

However, the rates of marijuana and opioid dependence were almost threefold higher in the United States and Canada (a region called “high-income North America” in the report) than in the rest of the world, with an estimated 749 cases of marijuana dependence and 650 cases of opioid dependence per 100,000 people.

Read more….

18 Years in the making- Italian Commission: A Damning Report on Military Vaccine Safety

This is chilling: pages 156 and 157 of the report, it is recalled that “vaccines for the military are identical to vaccines for children.” Page 154 after stating that the commission could not find “a single study demonstrating the safety of combination vaccines” on page 156 it says have “identified a significant risk of developing cancers and autoimmune disease after administration of combined and multidose vaccines, as recommended in the military prevention calendar “.

Italy has now removed childhood vaccine mandates.  Here is a summary of the Italian Commission’s damning report on Military Vaccine Safety.

  1. A very official parliamentary inquiry studying for 18 years the causes of unexplained cancers that strike military;
  2. It demonstrates that there is a link between vaccines inoculated to these soldiers and these cancers as well as autoimmune diseases;
  3. The vaccines in question are the same as those inoculated infants 8 weeks
  4. In France, while no major media speaks of this official report, ministers, MPs and experts awarded the Legion of Honor (while being economic link with pharmaceutical companies Vaccines vendors), continue to proclaim loudly that “vaccines are safe, it is scientifically proven that the report” benefit – risk “and in favor of vaccines! “READ MORE…

UNFORTUNATELY THE ARTICLE IS IN FRENCH. 

VLA Comment:  Check out this link confirming that Italy has suspended its mandatory vaccine programs

Aluminum Adjuvants in Vaccines: Testing a substitute adjuvant with new HepB shot

In February 2018, the FDA and CDC approved the recommendation for a new hepatitis B vaccine, Heplisav-B targeting adults over the age of 18. The U.S. Food and Drug Administration (FDA) had twice rejected the application for licensure for Heplisav-B in the past four years because of safety signals. Heplisav-B differs from other licensed hepatitis B vaccines in that it contains a new synthetic adjuvant known as cytosine phosphoguanine 1018 (CpG 1018) composed of short synthetic DNA molecules. In 2016, the FDA rejected an application for licensure for the Heplisav-B vaccine, because the agency was concerned about an increased rate of heart attacks and deaths in people who had been given the vaccine. During the trial, approximately 14 subjects had heart attacks. In July 2017, the FDA committee convened to re-evaluate the scientific evidence and make a decision on whether Heplisav B should or should not be approved for use in the U.S. This committee had only one cardiologist on the team, Milton Packer, MD, who is a distinguished scholar in cardiovascular science at the Baylor University Medical Center in Dallas, Texas. According to Dr. Packer, it was possible that the Heplisav B vaccine’s novel adjuvant was related to the higher number of heart attacks in study participants who received the experimental vaccine. He stated: “To know if the 7 -1 heart attack imbalance represented a real risk, we’d need comparative data in 50,000 people.” However, the only way to conduct such a large trial would be to approve the vaccine and see what happens in the public. With Dr. Packer abstaining in his vote to recommend the vaccine, the FDA committee approved it anyway. Dr. Packer stated: “Why did I abstain? Based on the available data, it was impossible for anyone to know if the increase in heart attack risk was real. There is a simple rule in life: if you don’t know, you should say you don’t know.” The vaccine is now available to the public, and all those who receive it are basically guinea pigs to find out if heart attacks will result from the experimental vaccine, and if it will continue to have FDA approval.

Read more…

[Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].

Study on combining Aluminum with 1018   (CPG1018 as above)

Study: Cytochrome P450 1A1 and 1B1 promoter CpG island methylation regulates rat liver injury induced by isoniazid

HPV (Gardasil) Cochrane BOGUS STUDY details

What happened to Cochrane?

Cochrane, a non-profit organization whose research helps individuals make informed health decisions, published a review in May 2018 claiming that the HPV vaccine helps prevent cancer and precancerous changes in the cervix with no serious side effects. The review aimed to increase public confidence in the HPV vaccine – both its efficacy in cancer prevention and its long-term safety. This publication has the potential to affect the opinions of many people regarding the HPV vaccine, possibly reassuring some parents and convincing them to choose it
for their children. READ ARTICLE

VLA Comment: The article is interesting to read however, the link to the BMJ review of the HPV Cochrane study shows the poor and fallacious design of the study whose conclusion is that the HPV vaccine is safe.  The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias

Pilot Study: Non-invasive therapy eliminates Aluminum from Alzheimer patients

Non-invasive therapy to reduce the body
burden of aluminium in Alzheimer’s disease

Abstract. There are unexplained links between human exposure to aluminium and the incidence, progression and aetiology of Alzheimer’s disease. The null hypothesis which underlies any link is that there would be no Alzheimer’s disease in the effective absence of a body burden of aluminium. To test this the latter would have to be reduced to and retained at a level that was commensurate with an Alzheimer’s disease-free population. In the absence of recent human interference in the biogeochemical cycle of aluminium the reaction of silicic acid with aluminium has acted as a geochemical control of the biological availability of aluminium. This same mechanism might now be applied to both the removal of aluminium from the body and the reduced entry of aluminium into the body while ensuring that essential metals, such as iron, are unaffected. Based upon the premisethat urinary aluminium is the best non-invasive estimate of  body burden of aluminium patients with Alzheimer’s disease were asked to drink 1.5 L of a silicic acid-rich mineral water each day for five days and, by comparison of their urinary excretion of aluminium pre-and post this simple procedure, the influence upon their body burden of aluminium was determined. Drinking the mineral water increased significantly (P <0.001) their urinary excretion of silicic acid (34.3 ± 15.2 to 55.7 ± 14.2 μmol/mmol
creatinine) and concomitantly reduced significantly (P = 0.037) their urinary excretion of aluminium (86.0 ± 24.3 to 62.2 ± 23.2 nmol/mmol creatinine). The latter was achieved without any significant (P >0.05) influence upon the urinary excretion of iron (20.7 ± 9.5 to 21.7 ± 13.8 nmol/mmol creatinine). The reduction in urinary aluminium supported the future longer-term
use of silicic acid as non-invasive therapy for reducing the body burden of aluminium in Alzheimer’s disease.

Click here for Pilot Study